01 1Hetero Drugs
01 1METOPROLOL SUCCINATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-09-27
Pay. Date : 2019-07-29
DMF Number : 33624
Submission : 2019-07-17
Status : Active
Type : II
20
Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is METOPROLOL SUCCINATE, with a corresponding US DMF Number 33624.
Remarkably, this DMF maintains an Active status since its submission on July 17, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 27, 2019, and payment made on July 29, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
